Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.

Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB

Open source

DOI
10.1158/1535-7163.mct-24-1060
Published
2025 Sep 2
Container
Molecular cancer therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-24-1060,
  title = {Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.},
  author = {Lindland K and Westrøm S and Dragovic SM and Li RG and Malenge MM and Ho B and Juzeniene A and Bønsdorff TB},
  year = {2025},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-24-1060},
  url = {https://doi.org/10.1158/1535-7163.mct-24-1060}
}

RIS

TY  - JOUR
TI  - Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.
AU  - Lindland K
AU  - Westrøm S
AU  - Dragovic SM
AU  - Li RG
AU  - Malenge MM
AU  - Ho B
AU  - Juzeniene A
AU  - Bønsdorff TB
PY  - 2025
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-24-1060
UR  - https://doi.org/10.1158/1535-7163.mct-24-1060
ER  - 

APA

K, L., S, W., SM, D., RG, L., MM, M., B, H., A, J., & TB, B. (2025). Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-24-1060

Source records